Apak-212 -

AKAP‑212 displayed potent bactericidal activity against all tested MDR Gram‑negative isolates. Time‑kill curves (Figure 1) showed >3 log₁₀ CFU reduction within 2 h at 4× MIC, confirming rapid killing kinetics.

The versatility of the APAK-212 allows it to serve a variety of high-stakes environments. Below are the three most common deployment scenarios. APAK-212

Dye‑leakage assays revealed a steep concentration‑response with EC₅₀ ≈ 1 µg mL⁻¹, suggesting membrane permeabilization as the primary mode of action. TEM images (Figure 2) demonstrated extensive outer membrane rupture without intracellular granule formation, consistent with a toroidal pore mechanism. Solid‑state NMR indicated a ~30° tilt angle relative to the bilayer normal, supporting insertion of the helical peptide into the lipid core. APAK-212